Georgia Urology is bringing a new prostate cancer treatment to the Northeast Georgia region. NanoKnife, the AngioDynamics system recognized by TIME as one of its Best Inventions of 2025, is a ...
The CAPTAIN trial compared the MRI-Guided TULSA Procedure™ to robotic radical prostatectomy for localized prostate cancer.
New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in ...
An MRI before treatment in men undergoing radical prostatectomy can provide independent prognostic value for oncologic ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
Investigators developed and validated new PSMA-PET-based nomograms for prognostication across prostate cancer stages to help ...
Foley, was diagnosed with Stage 2 breast cancer in October. She owed her diagnosis to a secondary screening, similar to an ultrasound, biopsy or other diagnostic test. Now, ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
For its 2nd anniversary, Callisto DataHub offers free annotated datasets of 50 suspected lung cancer X-rays and 50 ...
Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) procedure on the East Coast using the Vanquish(R) ...
MedPage Today on MSN
Ultrasound treatment for prostate cancer has early advantage versus prostatectomy
Better continence, erectile function, but data on oncologic outcomes still 2 years away ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results